Indranil Sen, CFO, Biocon resigned
Sen spent a decade with Biocon and held various key roles,
Sen spent a decade with Biocon and held various key roles,
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
The drug will target specific genetic mutations prevalent in certain types of cancers
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The institution will be spread over an area of more than 8 acres
Women emerge as the cornerstone of this monumental undertaking
The investment will catalyse various components of the IndiaAI Mission
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Subscribe To Our Newsletter & Stay Updated